UA91960C2 - Жидкие фармацевтические композиции fsh и lh - Google Patents

Жидкие фармацевтические композиции fsh и lh

Info

Publication number
UA91960C2
UA91960C2 UAA200509209A UA2005009209A UA91960C2 UA 91960 C2 UA91960 C2 UA 91960C2 UA A200509209 A UAA200509209 A UA A200509209A UA 2005009209 A UA2005009209 A UA 2005009209A UA 91960 C2 UA91960 C2 UA 91960C2
Authority
UA
Ukraine
Prior art keywords
fsh
pharmaceutical formulations
pluronic
liquid pharmaceutical
formulations
Prior art date
Application number
UAA200509209A
Other languages
English (en)
Ukrainian (uk)
Inventor
Фабрицио Самаритани
Пьерджорджо Донате
Original Assignee
Эйрес Трейдинг С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эйрес Трейдинг С.А. filed Critical Эйрес Трейдинг С.А.
Publication of UA91960C2 publication Critical patent/UA91960C2/ru

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение относится к медицине, касается фармацевтических композиций фоликулостимулирующего гормона (FSH) и смесей FSH с лютеинизирующим гормоном (LH) и способов получения таких композиций. Изобретение предлагает жидкую композицию или лиофилизированную многодозированную композицию FSH с/без LH, которая содержит поверхностно-активное вещество плуроник F68, метионин и бактериостатический агент, выбранный из группы, которую составляют фенол и-крезол.
UAA200509209A 2003-04-02 2004-04-02 Жидкие фармацевтические композиции fsh и lh UA91960C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03100882 2003-04-02

Publications (1)

Publication Number Publication Date
UA91960C2 true UA91960C2 (ru) 2010-09-27

Family

ID=36806115

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200509209A UA91960C2 (ru) 2003-04-02 2004-04-02 Жидкие фармацевтические композиции fsh и lh

Country Status (4)

Country Link
CN (1) CN100488566C (ru)
ES (1) ES2358330T5 (ru)
UA (1) UA91960C2 (ru)
ZA (1) ZA200507287B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102309745B (zh) * 2008-09-17 2013-05-08 上海天伟生物制药有限公司 一种卵泡刺激素冻干针剂
CN101347613B (zh) * 2008-09-17 2011-10-26 上海天伟生物制药有限公司 几乎不含亚基的糖蛋白的组合物及其制备方法
US8329649B2 (en) * 2008-11-04 2012-12-11 Aska Pharmaceutical Co., Ltd. Aqueous composition containing follicle-stimulating hormone and histidine
CN102293756A (zh) * 2011-08-24 2011-12-28 蚌埠丰原涂山制药有限公司 一种尿促性素冻干粉针剂及其制备方法
CN104856951A (zh) * 2015-05-06 2015-08-26 华侨大学 一种卵泡刺激素透皮纳米乳剂及其制备方法
CN116549403A (zh) * 2019-11-28 2023-08-08 成都景泽生物制药有限公司 卵泡刺激素冻干制剂及其制备方法和用途
CN115429751B (zh) * 2022-09-21 2023-11-17 景泽生物医药(合肥)股份有限公司 一种人重组卵泡刺激素注射剂及其制备方法

Also Published As

Publication number Publication date
CN100488566C (zh) 2009-05-20
CN1795012A (zh) 2006-06-28
ZA200507287B (en) 2007-03-28
ES2358330T5 (es) 2018-12-03
ES2358330T3 (es) 2011-05-09

Similar Documents

Publication Publication Date Title
RS20050737A (en) Liquid pharmaceutical formulations fish and lh together with a non- ionic surfactant
WO2004026231A3 (en) Formulation for lipophilic agents
EP1425277B8 (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
WO2002070438A3 (en) Compositions for delivering bisphosphonates
MXPA04001523A (es) Dialdehidos de rapamicina.
MY129417A (en) Zinc-free and low-zinc insulin preparations having improved stability
WO2006055511A3 (en) Stable tablet formulation of tetrahydrobiopterin
WO2003026487A3 (en) Medical retrieval device
WO2006035417A3 (en) Dihydropyrimidine microcapsule - formulations
WO2003066661A3 (en) Human dr4 antibodies and uses thereof
UA91960C2 (ru) Жидкие фармацевтические композиции fsh и lh
AU2003255820A1 (en) Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
MXPA03007635A (es) P-tienilbencilamidas que sirven como agonistas de receptores para angiotensina-(1-7), metodo para su produccion, su uso y preparaciones farmaceuticas que las contienen.
CA2453646A1 (en) 5-cnac as oral delivery agent for parathyroid hormone fragments
WO2004066983A3 (en) Controlled release of highly soluble agents
WO2002034240A3 (en) Delayed and sustained release formulations and method of use thereof
MY144814A (en) Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant
AU2003267551A1 (en) Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
WO2004037167A3 (en) Methods of treating dry eye disease with lantibiotics
HK1065305A1 (en) Substituted 4-aminocyclohexanol derivatives
EP1273301A3 (en) Pharmaceutical preparations based on active ingredients susceptible to illict administration
WO2002066492A3 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques.
TH112701B (th) สูตรผสมทางเภสัชกรรม fsh และ lh
IL149899A0 (en) MODIFIED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING BUPROPION HCl AS ACTIVE SUBSTANCE
Tucker The First China AIDS/STD Conference: National Recognition of the International Pandemic